We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.76%
4 Financials 5.47%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HELE icon
851
Helen of Troy
HELE
$663M
$19.8M 0.02%
163,973
-66,286
-29% -$7.14M
OI icon
852
O-I Glass
OI
$1.39B
$19.8M 0.02%
1,206,982
+786,260
+187% +$12.1M
UTHR icon
853
United Therapeutics
UTHR
$26.3B
$19.7M 0.02%
89,699
+4,613
+5% +$1.06M
ZBH icon
854
Zimmer Biomet
ZBH
$17.7B
$19.7M 0.02%
161,910
+72,252
+81% +$8.06M
MRSH
855
Marsh
MRSH
$86.3B
$19.7M 0.02%
103,990
+75,387
+264% +$14.6M
DOW icon
856
Dow Inc
DOW
$21.6B
$19.7M 0.02%
359,247
-557,440
-61% -$28.5M
FICO icon
857
CALL
Fair Isaac
FICO
$28.7B
$19.7M 0.02%
16,900
-39,900
-70% -$40.2M
PM icon
858
PUT
Philip Morris
PM
$301B
$19.6M 0.02%
208,300
+73,300
+54% +$6.75M
WYNN icon
859
CALL
Wynn Resorts
WYNN
$10.1B
$19.6M 0.02%
214,800
+14,400
+7% +$1.28M
NTR icon
860
PUT
Nutrien
NTR
$32.7B
$19.5M 0.02%
346,200
+123,900
+56% +$7M
BNTX icon
861
PUT
BioNTech
BNTX
$22.6B
$19.5M 0.02%
184,600
HPP
862
Hudson Pacific Properties
HPP
$834M
$19.5M 0.02%
298,804
+41,291
+16% +$1.82M
AMH icon
863
American Homes 4 Rent
AMH
$12B
$19.5M 0.02%
541,307
+126,683
+31% +$4.42M
PTON icon
864
CALL
Peloton Interactive
PTON
$2.63B
$19.4M 0.02%
3,190,600
EQT icon
865
PUT
EQT Corp
EQT
$33.2B
$19.4M 0.02%
501,700
-139,800
-22% -$5.67M
EWBC icon
866
East-West Bancorp
EWBC
$17.9B
$19.4M 0.02%
268,977
-39,129
-13% -$2.36M
SPGI icon
867
S&P Global
SPGI
$126B
$19.3M 0.02%
43,915
+41,889
+2,068% +$16.5M
TPL icon
868
Texas Pacific Land
TPL
$28.9B
$19.2M 0.02%
110,142
+38,340
+53% +$7.29M
BIO icon
869
Bio-Rad Laboratories Class A
BIO
$8.42B
$19.2M 0.02%
59,354
+47,242
+390% +$14.8M
SIRI icon
870
SiriusXM
SIRI
$10B
$19.1M 0.02%
348,875
+336,477
+2,714% +$16.2M
AZPN
871
DELISTED
Aspen Technology Inc
AZPN
$19M 0.02%
86,474
+58,345
+207% +$11.2M
SHLS icon
872
Shoals Technologies Group
SHLS
$1.58B
$19M 0.02%
1,223,122
-78,838
-6% -$1.19M
SKX
873
DELISTED
Skechers
SKX
$19M 0.02%
304,572
-146,674
-33% -$7.9M
TW icon
874
Tradeweb Markets
TW
$21.3B
$19M 0.02%
208,698
+70,468
+51% +$6.29M
GIII icon
875
G-III Apparel Group
GIII
$1.47B
$19M 0.02%
557,878
-135,073
-19% -$3.8M

Similar funds

D.E. Shaw & Co's Q4 2023 Portfolio in Review

As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
  • D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
  • D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.